NATIONAL BANK OF CANADA /FI/ - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 87 filers reported holding SUMMIT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.

Quarter-by-quarter ownership
NATIONAL BANK OF CANADA /FI/ ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,805
-30.1%
1,6000.0%0.00%
Q2 2023$4,013
+44.9%
1,6000.0%0.00%
Q1 2023$2,770
-79.8%
1,600
-50.6%
0.00%
Q4 2022$13,738
+243.4%
3,2410.0%0.00%
Q3 2022$4,000
+33.3%
3,2410.0%0.00%
Q2 2022$3,000
-62.5%
3,2410.0%0.00%
Q1 2022$8,000
-11.1%
3,2410.0%0.00%
Q4 2021$9,0003,2410.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Polar Capital Holdings Plc 5,800,000$27,260,0000.16%
Inscription Capital, LLC 17,000$80,0000.03%
ExodusPoint Capital Management, LP 185,844$873,0000.01%
HoyleCohen, LLC 10,359$49,0000.01%
Virtu Financial LLC 10,835$51,0000.01%
Tower Research Capital LLC (TRC) 3,783$18,0000.00%
Renaissance Technologies 253,212$1,190,0000.00%
Baillie Gifford 372,261$1,749,0000.00%
CAPSTONE INVESTMENT ADVISORS, LLC 37,238$175,0000.00%
BREWIN DOLPHIN LTD 1,970$9,2590.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders